ST. LOUIS, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Azuria Water Solutions, a leader in technology-enabled water solutions, today announced the acquisition of Waterline Renewal Technologies (TM) (Waterline).

The FDA has approved Dupixent (dupilumab) for the treatment of adult and pediatric patients aged 6 years and older with allergic fungal rhinosinusitis.

San Francisco 49ers fullback Kyle Juszczyk’s wife, Kristin, caught people's attention with her new NBA collection. She ...

Behrman Capital ("Behrman"), a private equity investment firm based in New York, today announced the sale of its portfolio company Waterline Renewal Technologies ("Waterline" or the "Company") to ...

Behrman Capital has sold Waterline Renewal Technologies, an Ottawa, Illinois-based provider of engineered products for the trenchless rehabilitation of wastewater infrastructure. The buyer was Azuria ...

Geospatial experts in Liberia are urging the government to prioritize digital mapping as a key tool for urban development, saying the technology could transform city planning, infrastructure ...

Sanofi and Regeneron’s Dupixent approved in the US as the first and only medicine for allergic fungal rhinosinusitisApproval in adults and ...

Talk about being a cheapskate. There’s no denying that the cost of weddings have gotten out of hand. While soon-to-be brides ...

Approval in adults and children aged 6 years and older supported by Phase 3 trial demonstrating Dupixent significantly reduced nasal signs and ...

Sanofi and Regeneron’s Dupixent approved in the US as the first and only medicine for allergic fungal rhinosinusitisApproval in adults and children aged 6 years and older supported by phase 3 study ...

US FDA approves Sanofi and Regeneron’s Dupixent for allergic fungal rhinosinusitis: Paris Thursday, February 26, 2026, 15:00 Hrs [IST] The US Food and Drug Administration (FDA) ...